Département de Chimie, Bureau International des Poids et Mesures (BIPM), Pavillon de Breteuil, 92312, Sèvres Cedex, France.
Anal Bioanal Chem. 2013 Oct;405(25):8039-51. doi: 10.1007/s00216-013-6953-7. Epub 2013 May 25.
It is common practice to quantify the mass concentration of a peptide solution through quantitative determination of selected chemically stable amino acids produced following complete hydrolysis of the parent peptide. This is because there is generally an insufficient quantity of material available to allow for the obvious alternative of a direct purity analysis characterization of the parent peptide, and the subsequent constitution of a calibration solution. However, selected accurately characterized pure peptide reference materials are required to establish reference points for the dissemination of metrologically traceable measurements and to develop reference measurement systems for laboratory medicine. In principle, purity assignment of a peptide can be performed by using the so-called mass balance approach, by employing a range of analytical techniques to obtain an estimate of the mass fraction content of all impurities present in the intact peptide, and by utilizing the difference from the theoretical limit value to assign the mass fraction content of the main peptide. Liquid chromatography-high-resolution tandem mass spectrometry (LC-hrMS/MS) is a key technique for the detection, identification, and determination of structurally related impurities present in a peptide material, and experiments characterizing the model peptide hormone angiotensin I (ANG I) are described in the present work. Degradation products that were generated from ANG I after storage at elevated temperatures were screened. The formation of peptide fragments such as ANG II or ANG III was determined by comparison of measured mass values with calculated mass values. The use of a data-dependent acquisition technique enabled the detection and structural characterization of ANG II and other peptide fragments as major impurities in the same LC-hrMS/MS analysis run. Subsequent quantification using external calibration allowed the mass fraction of the major impurities in a candidate reference material to be estimated as 10.4 mg/g. Failure to correct for these impurities would lead to a 1% error in the determination of the concentration of the peptide in solution by amino acid analysis techniques.
通常通过定量测定完全水解后的母体肽所产生的某些化学稳定的氨基酸来定量确定肽溶液的质量浓度。这是因为通常可获得的材料数量不足以允许对母体肽进行明显的直接纯度分析特性,以及随后组成校准溶液。但是,需要选择经过准确表征的纯肽参考物质,以建立用于传递计量可追踪测量的参考点,并为实验室医学开发参考测量系统。原则上,可以通过使用所谓的质量平衡方法来分配肽的纯度,该方法使用一系列分析技术来获得对存在于完整肽中的所有杂质的质量分数含量的估计,并利用与理论极限值的差异来分配主要肽的质量分数含量。液相色谱-高分辨串联质谱(LC-hrMS/MS)是检测、鉴定和确定肽材料中存在的结构相关杂质的关键技术,本工作中描述了对模型肽激素血管紧张素 I(ANG I)进行的实验。筛选了在高温下储存后从 ANG I 产生的降解产物。通过将测量的质量值与计算的质量值进行比较,确定了 ANG II 或 ANG III 等肽片段的形成。使用数据依赖采集技术,可以在相同的 LC-hrMS/MS 分析运行中检测和结构表征 ANG II 和其他肽片段作为主要杂质。随后使用外部校准进行定量,可估计候选参考物质中主要杂质的质量分数为 10.4mg/g。如果不纠正这些杂质,氨基酸分析技术测定溶液中肽浓度的误差将达到 1%。